New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

There are varying weight-loss solutions on the market today to meet the demand so many people have for slimmer bodies. One of the most effective solutions is weight loss pills. These pills not only ...

Learn more about GLP-1 pills and how they may be more convenient and cost-effective than the injections.

Popular weight-loss drug Wegovy is now available in pill form in the United States. Novo Nordisk, the Danish drugmaker behind ...

Add Yahoo as a preferred source to see more of our stories on Google. Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

For years, pharmaceutical companies have been racing to develop a market-ready GLP-1 weight-loss pill to join the ranks of popular injectables. Today, Novo Nordisk’s oral version of Wegovy is ...

By Maggie Fick and Michael Erman SAN FRANCISCO, Jan 12 (Reuters) - Eli Lilly's research and development head said on Monday the company will have plenty of supply to launch its much-anticipated new ...

FDA's new voucher could shorten drug review to 1-2 months Lilly's orforglipron targets high-burden chronic condition Analysts predict price erosion due to new market entrants Sept 16 (Reuters) - Eli ...

NEW YORK - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become available in January, ...

FILE PHOTO: Eli Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly’s international president Patrik Jonsson said on ...